Professor Bengt Winblad, MD, PhD, was until 2018 Head of the Division of Neurogeriatrics at Karolinska Institutet, Stockholm, Sweden. He is currently leading his own research group in the same division, focusing on drug development.

Dr. Winblad is Professor of Geriatric Medicine at Karolinska Institutet and Chief Physician at Karolinska University Hospital in Huddinge. From 2001 to 2019, he chaired the European Alzheimer Disease Consortium (EADC), currently consisting of 71 clinical research centers across Europe. Since 2009, he has been a member of the Senate for the German national network on neurodegenerative disorders, DZNE. He was PI of the first EU Joint Program project, BIOMARKAPD, aiming at standardizing sampling and measurement of biomarkers in Alzheimer’s and Parkinson’s diseases.

He founded several international conferences, including the International Conference on Alzheimer’s Disease and Related Disorders (ICAD, renamed AAIC) and the International PharmacoEconomic Conferences on AD (IPECAD). He was a member of the Nobel Assembly, Karolinska Institutet from 1988 to 2010.

In 2009, Dr. Winblad was recognized as the world’s most prolific researcher in Alzheimer’s disease by the Journal of Alzheimer’s Disease, and in 2016, as one (out of five from the Karolinska Institutet) of the most cited scientists worldwide. He has received numerous international and national awards for his research, the latest of which was the 2019 European Grand Prix for Research awarded by the Foundation for Research on Alzheimer research, France.